If you could vote on Brexit now which option would you choose?
   

Oxford Biomedica signs new deal to make AstraZeneca COVID shot


Britain's Oxford Biomedica said on Friday it had signed a new three-year agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022, but no volumes were defined in an indication of waning demand for the shot. Cell and gene therapy firm Oxford Biomedica said in April that it had manufactured more than 100 million doses of AstraZeneca's vaccine since their partnership began in September 2020. Commitments under the deal are scheduled to end this year.

Reuters - July 1, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/oxford-biomedica-signs-new-deal-make-astrazeneca-covid-shot-2022-07-01/